| NAME |
GADOTERIDOL 279.3MG/ML INJ,SYRINGE,17ML |
| VA GENERIC NAME |
GADOTERIDOL |
| DOSAGE FORM |
INJ |
| FDA MED GUIDE |
Gadoteridol_(Prohance)_(2020).pdf |
| ACTIVE INGREDIENTS |
|
| CS FEDERAL SCHEDULE |
Unscheduled |
| STRENGTH |
279.3 |
| SINGLE/MULTI SOURCE PRODUCT |
Single source |
| UNITS |
MG/ML |
| DSS NUMBER |
3 |
| NATIONAL FORMULARY NAME |
GADOTERIDOL INJ |
| CREATE DEFAULT POSSIBLE DOSAGE |
NO |
| POSSIBLE DOSAGES TO CREATE |
No Possible Dosages |
| CODING SYSTEM |
|
| COPAY TIER |
-
- COPAY TIER LEVEL: 0
- COPAY EFFECTIVE DATE: 2017-02-27 00:00:00
|
| PGX ELIGIBLE |
NO |
| PGX SUPPRESSED |
NO |
| VA PRINT NAME |
GADOTERIDOL 279.3MG/ML INJ SYRINGE 17ML |
| VA PRODUCT IDENTIFIER |
G0166 |
| TRANSMIT TO CMOP |
NO |
| VA DISPENSE UNIT |
SYR |
| MASTER ENTRY FOR VUID |
YES |
| VUID |
4012505 |
| EFFECTIVE DATE/TIME |
-
- 2005-03-10 00:00:00
- STATUS: ACTIVE
|
